健康病毒携带者中针对EB病毒裂解性和潜伏性抗原的CD8(+) T淋巴细胞频率
Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
作者信息
Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W
机构信息
Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Regensburg, D-93053, Germany.
出版信息
Virology. 1999 Nov 25;264(2):289-97. doi: 10.1006/viro.1999.9996.
We investigated CD8(+) T cell frequencies of five different Epstein-Barr virus-specific cytotoxic T lymphocyte epitopes located within proteins of the replicative cycle and the latent state in healthy long-term virus carriers with IFN-gamma enzyme-linked immunospot assay. Frequencies of the HLA-A3-restricted epitope RVRAYTYSK (RVR) whose minimal length was mapped in this study to amino acid position 148-156 of the immediate-early protein BRLF1 were compared with those of a further known HLA-A3-restricted epitope within EBNA3A, RLRAEAQVK (RLR). Determination of frequencies of CD8(+) T lymphocytes directed against lytic antigen epitope RVR revealed that only one of eight donors recognized this epitope. Frequency was calculated to be 65 RVR-specific CD8(+) T lymphocytes per 10(6) PBMC. None of the HLA-A3-positive donors exhibited IFN-gamma release after antigenic stimulation with the EBNA3A-specific peptide epitope RLR. Furthermore, we chose three known HLA-B8-restricted epitopes, RAKFKQLL (RAK), FLRGRAYGL (FLR), and QAKWRLQTL (QAK), of the lytic protein BZLF1 and the latent protein EBNA3A. Examination of eight HLA-B8-positive virus carriers revealed that the BZLF1-specific epitope RAK was recognized by all donors with a median frequency of 233 RAK-specific CD8(+) T lymphocytes per 10(6) PBMC. Only 50% of these donors reacted against EBNA3A-specific epitope FLR and a minority (25%) reacted against EBNA3A-specific epitope QAK.
我们采用干扰素-γ酶联免疫斑点试验,调查了健康长期病毒携带者中,位于复制周期蛋白和潜伏状态蛋白内的5种不同的爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞表位的CD8(+) T细胞频率。将HLA-A3限制性表位RVRAYTYSK(RVR)的频率与EBNA3A中另一个已知的HLA-A3限制性表位RLRAEAQVK(RLR)的频率进行比较,本研究中已确定RVR的最小长度对应于早期蛋白BRLF1的第148 - 156位氨基酸。针对裂解抗原表位RVR的CD8(+) T淋巴细胞频率测定显示,8名供体中只有1人识别该表位。计算得出频率为每10(6)个外周血单核细胞中有65个RVR特异性CD8(+) T淋巴细胞。在用EBNA3A特异性肽表位RLR进行抗原刺激后,HLA-A3阳性供体均未表现出干扰素-γ释放。此外,我们选择了裂解蛋白BZLF1和潜伏蛋白EBNA3A的3个已知的HLA-B8限制性表位,即RAKFKQLL(RAK)、FLRGRAYGL(FLR)和QAKWRLQTL(QAK)。对8名HLA-B8阳性病毒携带者的检测显示,所有供体均识别BZLF1特异性表位RAK,中位数频率为每10(6)个外周血单核细胞中有233个RAK特异性CD8(+) T淋巴细胞。这些供体中只有50%对EBNA3A特异性表位FLR有反应,少数(25%)对EBNA3A特异性表位QAK有反应。